AstraZeneca Pharmaceuticals (Ireland) DAC (AstraZeneca)

Lobbying Organisation AstraZeneca Pharmaceuticals (Ireland) DAC

Date published 20 Sep, 2024

Relevant Matter Public policy or programme

Public Policy Area Health

Period 1 May, 2024 to 31 Aug, 2024

Specific Details Meeting to discuss the EU Pharmaceutical legislation

Intended results Discussion on Ireland’s stance on the proposed revision of the EU general pharmaceutical legislation and opportunities to feed into consultations with industry.

Name of person primarily responsible for lobbying on this activity Stefan Woxström, Andrea Mugan, Alex Wilkes, Nicola Fullam

Did any Designated Public Official(DPO) or former Designated Public Official(DPO) carry out lobbying activities on your behalf in relation to this return? You must include yourself, and answer Yes, if you are a current DPO or a DPO at any time in the past. (What is a Designated Public Official?) No

Did you manage or direct a grassroots campaign? No

Was this lobbying done on behalf of a client? No

Lobbying activity

The following activities occurred for this specific Subject Matter Area.

Meeting (1)

Designated public officials lobbied

The following DPOs were lobbied during this return period on this specific Subject Matter Area. These DPOs were involved in at least one of the Lobbying Activities listed above, but not necessarily all of them. As returns are specific to a Subject Matter Area the above Lobbying Activities may be associated with multiple returns.

John Newham Assistant Secretary (Department of Enterprise, Trade and Employment)